Company intelligence / Profile preview

Utermöhlen

Wolvega, Netherlands

Ownership: Private
Development stage: Other

Overview

Koninklijke Utermöhlen markets long-established wound-care, first-aid and cryotherapy products that are widely used in primary care and consumer settings, with a long commercial track record rather than clinical-trial-style results.

Therapeutic areas: OtherWomen's HealthDermatologyInfectious Diseases
Industry: Consumable Medical Devices

Partnerships

Works with “market-leading distributors” globally for cryotherapy and other self-care products, but specific named pharma/biotech partners are not disclosed.

Beyond the preview

Go deeper on Utermöhlen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Utermöhlen.

Explore the full profile